Latest News about pharmaceutical
Recent news which mentions pharmaceutical
Gilead's Lenacapavir Plan Faces Global Hurdles As It Commits To No-Profit Access for 2 Million
July 09, 2025
From Benzinga
Analyst Views Mixed As Amgen's Weight Loss/Diabetes Drug MariTide Shows Promise But Has Dose Issues
June 24, 2025
From Benzinga
From Benzinga
Novartis' Fabhalta Delivers Hemoglobin Gains, Reduces Fatigue In Patients With Rare Blood Disorder
June 12, 2025
From Benzinga
From Benzinga
AbbVie Scores FDA Approval For Its Blockbuster Drug Rinvoq To Treat Type Of Arthritis
April 29, 2025
From Benzinga
Eli Lilly Rallies Over 14%, Notches Best Day Since June 2000 On Oral Weight-Loss Drug Results: Analysts React
April 17, 2025
From Benzinga
Neurocrine Biosciences' Positive Crenessity Physician Survey Turns This Analyst Bullish
April 15, 2025
Tickers
NBIX
From Benzinga
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies
April 11, 2025
From Benzinga
Tempest Weighs M&A, Analyst Sees A "Broken Story" Despite Phase 2 Liver Cancer Study Success
April 10, 2025
From Benzinga
Cartesian Therapeutics Reports Strong 12-Month Data For Lead Cell Therapy In Myasthenia Gravis Patients
April 08, 2025
From Benzinga
From Benzinga
Edgewise Therapeutics Sees Meaningful HCM Treatment Gains With EDG-7500 In Phase 2 Study
April 02, 2025
From Benzinga
Vertex Discontinues Development Of Type 1 Diabetes Candidate After Disappointing Data
March 31, 2025
From Benzinga
Sensei Biotherapeutics Reports Favorable Initial Clinical Activity Data For Solnerstotug In Resistant Tumors
March 28, 2025
From Benzinga
Johnson & Johnson's Golden Cross: Technical Momentum Meets Groundbreaking Lung Cancer Breakthrough
March 20, 2025
Tickers
JNJ
From Benzinga
Regenxbio Touts Positive Biomarker Data From Duchenne Muscular Dystrophy Gene Therapy Trial
March 19, 2025
Tickers
RGNX
From Benzinga
FDA Grants Fast Track Review To Johnson & Johnson's Nipocalimab For Autoimmune Disorder That Affects Tears, Saliva
March 18, 2025
From Benzinga
Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases
December 18, 2024
From Benzinga
FDA Rejects Johnson & Johnson's Injectable Version Of Approved Drug For Lung Cancer
December 17, 2024
From Benzinga
Arizona Pharmacy Association Appoints Garet Turner as New CEO
December 05, 2024
From PRLog
Syros Pharmaceuticals Stock Sinks As Pivotal Blood Cancer Trial Flunks, Triggers Loan Default
November 13, 2024
From Benzinga
From Benzinga
Stock Of The Day: Here's Why Weight-Loss Drug Maker Eli Lilly Has Reversed
September 06, 2024
Tickers
LLY
From Benzinga
What's Going On With Eli Lilly and Company Shares Friday
August 02, 2024
From Benzinga
Stock Of The Day: Moderna Stock Plunges, Breaking Key Support Levels Following Earnings Report
August 01, 2024
Tickers
MRNA
From Benzinga
Why Evoke Pharma (EVOK) Stock Is Volatile
July 30, 2024
From Benzinga